Author:
Miller P. D.,Recker R. R.,Reginster J.-Y.,Riis B. J.,Czerwinski E.,Masanauskaite D.,Kenwright A.,Lorenc R.,Stakkestad J. A.,Lakatos P.
Publisher
Springer Science and Business Media LLC
Subject
Endocrinology, Diabetes and Metabolism
Reference25 articles.
1. National Institutes of Health 2000 Osteoporosis Prevention, Diagnosis, and Therapy. NIH Consensus Statement Online March 27–29 17:1–36. http://consensus.nih.gov/2000/2000Osteoporosis111html.htm . Accessed 10 March 2010
2. Adachi JD, Loannidis G, Berger C, Joseph L, Papaioannou A, Pickard L, Papadimitropoulos EA, Hopman W, Poliquin S, Prior JC, Hanley DA, Olszynski WP, Anastassiades T, Brown JP, Murray T, Jackson SA, Tenenhouse A, Canadian Multicentre Osteoporosis Study (CaMos) Research Group (2001) The influence of osteoporotic fractures on health-related quality of life in community-dwelling men and women across Canada. Osteoporos Int 12:903–908
3. Rahmani P, Morin S (2009) Prevention of osteoporosis-related fractures among postmenopausal women and older men. CMAJ 181:815–820
4. Zizic TM (2004) Pharmacologic prevention of osteoporotic fractures. Am Fam Physician 70:1293–1300
5. Chesnut CH III, Skag A, Christiansen C, Recker R, Stakkestad JA, Hoiseth A, Felsenberg D, Huss H, Gilbride J, Schimmer RC, Delmas PD, Oral Ibandronate Osteoporosis Vertebral Fracture Trial in North America and Europe (BONE) (2004) Effects of oral ibandronate administered daily or intermittently on fracture risk in postmenopausal osteoporosis. J Bone Miner Res 19:1241–1249
Cited by
46 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献